Life sciences vet Arthur Tzianabos leaves Shire, joins OvaScience as CSO

After more than eight years in various roles at Shire including his most recent role as senior vice president and head of research and early development, Arthur Tzianabos said good-bye to the biopharmaceutical company and hello to OvaScienceSM (Nasdaq: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.